Efficacy of Ketogenic Diets on Type 2 Diabetes: a Systematic Review.
Delphine TinguelyJustine GrossChristophe KosinskiPublished in: Current diabetes reports (2021)
To assess the pleiotropic effects of ketogenic diets (KD) on glucose control, changes in medication, and weight loss in individuals with type 2 diabetes, and to evaluate its practical feasibility RECENT FINDINGS: KD results in improved HbA1c already after 3 weeks, and the effect seems to persist for at least 1 year. This is associated with a reduction in glucose-lowering medications. The weight loss observed after a short time period seems to be maintained with a long-term diet. Adequate support (supportive psychological counseling, enhancing positive affectivity, reinforcing mindful eating) is necessary to achieve a benefit and to assure adherence. Despite the documented decrease in HbA1, a definitive causal effect of KD remains to be proven. KD should be performed under strict medical supervision. Future research should clarify how compliance can be maximized and how ketosis can be optimally monitored.
Keyphrases
- weight loss
- glycemic control
- bariatric surgery
- blood glucose
- roux en y gastric bypass
- type diabetes
- gastric bypass
- healthcare
- weight gain
- obese patients
- insulin resistance
- current status
- smoking cessation
- locally advanced
- adipose tissue
- squamous cell carcinoma
- body mass index
- skeletal muscle
- metabolic syndrome
- physical activity
- adverse drug
- preterm birth
- drug induced